Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once‐daily Long‐acting Beta₂‐agonists/inhaled Corticosteroids Combined Inhalers Versus Inhaled Long‐acting Muscarinic Antagonists for People With Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439664/1/images/repview. Accessed 07 June 2024.
Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439664/1/images/repview. Accessed June 7, 2024.
Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439664/1/images/repview
Once‐daily Long‐acting Beta₂‐agonists/inhaled Corticosteroids Combined Inhalers Versus Inhaled Long‐acting Muscarinic Antagonists for People With Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2024 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439664/1/images/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
ID - 439664
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439664/1/images/repview
DB - Evidence Central
DP - Unbound Medicine
ER -